New Means to Reactivate p53 in Leukemia With Drs. Omar Abdel-Wahab, Ulrich Steidl, and Amit Verma
In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other forms of cancer. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8673.aspx.
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other forms of cancer. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8673.aspx.
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
